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We investigated the effects of breathing air warmed and fully saturated to body temperature
(AWS) before, during, and after exercise in asthmatic subjects. Airway responses to submaxi-
mal exercise on a cycloergometer were measured on four separate days in 14 asthmatic
volunteers. On day I the subjects exercised breathing ambient air(AA). On the subsequent three
days exercise was performed with the subjects breathing AWS, (I) for five minutes preceding,
(2) during, and (3) for five minutes following exercise. We showed complete protection against
EIB by AWS during exercise, but no protection by AWS before or after exercise. On two
subsequent days we examined the effects of partially warming and humidifying the subjects'
inspired air by having them wear a mask during exercise. We found that with such protection
bronchospasm was significantly but not completely blunted. We conclude that the physiologic
changes initiated during exercise can be prevented by breathing AWS during exercise, but are
not by AWS inhaled before or after exercise. Furthermore, these studies demonstrate the
possibility of using masks as a non-pharmacologic means of controlling EIB.
INTRODUCTION
Physical exertion is known to precipitate clinical bronchospasm in many asthmat-
ics [1-3]. Airway obstruction occurs within a few minutes after cessation of exercise
and gradually subsides after several hours. It is well recognized that asthmatics who
demonstrate exercise-induced bronchospasm (EIB) have more severe attacks in cold
weather, and Strauss et al. [4] have recently shown that the bronchoconstrictor effect
of exertion can be markedly enhanced by having EIB susceptible patients breathe
cold dry air during exercise. Deal et al. [5] have demonstrated that this phenomenon
is directly related to respiratory heat exchange (RHE) in the airways ofsubjects with
asthma, and that RHE can be directly correlated with the severity of pulmonary
function deterioration following exercise.
Respiratory heat exchange (RHE) is a quantitative representation of heat flux in
the tracheobronchial tree, and may be expressed by the formula:
RHE = VE [HC(Ti - Te) + HV (WCi - WCe)]
where RHE is the respiratory heat exchange in Kcal/min; VE, minute ventilation in
e/min (BTPS): HC, heat capacity of air (0.000304 Kcal/e per °C); Ti, inspired air
temperature (°C); Te, expired air temperature (°C); HV, latent heat of vaporization
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of water (0.58 Kcal/g); WCi, water content of inspired air in MgH2O/e; WCe, water
content of expired air in MgH2O/e [5].
We sought to further explore some practical implications of these relations in
asthmatic subjects by increasing inspired air temperature and humidity and thereby
altering RHE. We determined the influence of breathing air warmed and saturated to
body temperature before, during, and after exercise in order to better understand
how modifying inspired air conditions could alter EIB. We further investigated the
therapeutic potential of wearing a mask during exercise as a means of partially
warming and humidifying inspired air to body conditions in order to determine
whether non-pharmacologic methods might be useful in the management of EIB.
SUBJECTS AND METHODS
Exercise challenge studies were performed on asthmatic subjects who were selected
because of a history strongly suggestive of EIB. All the subjects were otherwise
healthy non-smoking young adults aged 24.9 ± 6.8 years (mean ± 1 SD). There were
nine male and five female subjects. All had a past history ofasthma as defined by the
American Thoracic Society [6]. The subjects were mild asthmatics; none had ever
required steroid therapy or disodium cromoglycate for control oftheir disease. None
had been hospitalized. All subjects gave informed consent as approved by the Yale
University Human Investigation Committee.
In all cases, exercise studies were performed at least twenty-four hours after
cessation of a subject's usual asthma medications, and exercise challenge took place
at approximately the same time of day for each individual to avoid any possible
effects of diurnal variation.
Pulmonary function was assessed using partial and maximal expiratory flow
volume curves. These measurements were performed using a pneumotachograph
integrator system [7] and the results were recorded on an X-Y recorder (Gould Brush
500, Cincinnati, OH) with flow plotted against volume. For each test the subject
inspired to approximately 70 percent of vital capacity and then exhaled forcefully to
residual volume. The subject then inhaled to total lung capacity and once again
forcefully exhaled to his residual volume. These maneuvers generated partial and
maximal expiratory flow volume (PEFV and MEFV) curves (see Fig. 1). From these
plots, the forced vital capacity (FVC), forced expired volume in one second (FEVI),
FIG. 1. Partial and maximal
expiratory flow volume (PEFV
and MEFV) curves. Partial and
maximal flow rates are measured
at a volume point which is 60
percent of the average baseline
vital capacity below TLC. Forced
expired volume in one second is
4 _ wPEFR indicated by a one second marker
on the MEFV curve. TLC =
n lX \/ oPEFVCURVE Total Lung Capacity; PEFR =
3 2 _ \ M MEF40% Peak Expiratory Flow Rate;
_ - < FEV, FEV one second forced ex- pired volume, MEF400o and
0 1 2 3 VOLUME MEASURED MEF40%(P)
= Maximal expira-
\ /
4 FROM TLC (liters)
tory flow at 60 percent of vital
capacity below TLC measured on
MEFV and PEFV curves, respec-
60% OF VITAL CAPACITY tively.
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and peak expiratory flow rate (PEFR) as well as maximal expiratory flow rates on
maximal (MEF40%) and partial (MEF40%(P)) flow volume curves at 60 percent of
the control vital capacity below TLC were determined [8]. Flows were measured at
this level rather than at 50 percent of VC in order to avoid the "transient" peak flow
level on the partial flow volume curve.
All exercise studies were performed on a cycloergometer (Monark). Subjects
underwent progressive exercise testing on their first study day to determine an
exercise load that would achieve a submaximal effort asjudged by a heart rate of 150
beats/minute or better. The same exercise load was used on each subsequent test day
for the subjects. During these studies exercise was increased by a fixed increment of
150 Kilopond meters per minute(Kpm/min) every minute as described by Jones et al.
[9]. In a previous study [10] we have shown that such a challenge elicits some degree
of EIB in virtually all asthmatics tested. The subject's heart rate was measured at the
end of every minute by monitoring the electrocardiographic pattern (Hewlett
Packard, Model 1500B, Waltham, MA). Minute ventilation (VE) was measured at
the end of each minute by directing exhaled air through a calibrated gas meter.
Inspired air was channeled through an Otis McKerrow valve (Warren E. Collins,
Braintree, MA), directing room or conditioned air into the subject's airway and
exhaled air through the gas meter (Fig. 2). This system was not used during the
second study as the subjects were wearing masks and it was not possible to measure
their minute ventilation in this fashion.
The laboratory in which the studies were performed was centrally air-conditioned
and both the room temperature and humidity were kept within narrow limits:
T = 22.6 ± 1.620C. Relative Humidity (RH) = 37.5 ± 4.4% (mean ± SD). These were
considered our ambient air (AA) conditions.
Two series of studies were performed. In the first (Study I) we examined the effect
of warming and humidifying inspired air before, during, and after exercise. Ten
subjects participated. On the first day of the study, the subject exercised breathing
ambient air (AA). On the subsequent three days the exercise challenge was repeated
to the same work-load level. On these three days, the subjects breathed air warmed
and fully saturated to body temperature (AWS) by passage through a heated cascade
humidifier (Puritan Bennett, No. 008926, Kansas City, MO) filled with sterile water,
and connected to the inspiratory port of the Otis-McKerrow valve (see Fig. 2).
Subjects wore a nose clip to assure that only the conditioned air, AWS or AA, was
inhaled, and that the "air-conditioning" effects of nasopharynx were bypassed.
Temperature was measured at the proximal opening of the valve, and the humidifier
temperature setting was adjusted to maintain inspired air temperature at 370C. On
OTIS-McKERROW
VALVE
OUTLET ONLE
OUTLETN SUBJECT GAS- METER
BICYCLE
FIG. 2. Schematic representa-
HEATED CASCADE tion of the system used to deliver
HUMIDIFIER AWS to the subjects.each of the study days the subject inhaled modified air for five minutes before,
during, and after exercise, respectively. Pulmonary function was measured prior to
exercise, immediately following exercise, and six minutes following the cessation of
exercise. All measurements were repeated three times at intervals of one minute and
the results averaged from each of the time periods [10].
In the second series of the studies (Study II), ten subjects (refer to Table 1) were
used (six of whom had participated in the initial series of studies). The study
consisted of two separate days on which exercise challenge was performed. As in the
first study, the initial day consisted ofa submaximal exercise challenge performed on
a cycloergometer, to document the degree of EIB experienced by each subject under
AA conditions. This challenge differed from those of the first study in that subjects
were not forced to breathe through their mouths by the use of a nose-clip during
exercise. On the second day the same format was followed except that this time
subjects wore a mask (3M, MicroporeT.M.germ and pollen mask) during the exercise
period.
Following the final post-exercise measurements of pulmonary function, subjects
received two inhalations from a standard nebulizer containing metaproterenol. Post
bronchodilator pulmonary function was measured ten minutes following inhalation.
RESULTS
Baseline pulmonary function studies performed on the subjects in the first study
day of both experiments revealed mild airway obstruction (Table 1). The average
(mean ± SD) exercise load achieved during the studies was 945 ± 147 kpm/min.
Maximal heart rates and ventilations aredetailed in Table 2 for individual study days
and show no significant differences. Baseline pulmonary function of the initial sutdy
days was compared with baseline function of the subsequent study days (Table 3).
No significant differences were demonstrated by a one-way analysis of variance
(p > 0.05) for Study I days and by the paired t-test for Study 11 days (p > 0.05)[11].
Significant exercise-induced bronchospasm was demonstrated on the initial study
day of both studies (refer to Table 4). In ourfirst study, when subjects were exercised
breathing air warmed to body temperature and humidified by the heated cascade
humidifier, we did not observe significant post-exercise bronchospasm for the group
as a whole. However, one individual did manifest a 10 percent fall in FEV, and two
decreased their MEF40%(P) by more than 20 percent. Both ofthese changes were less
than the corresponding decreases of the initial day. Furthermore, both individuals
demonstrated a sequential decrease in flow rates following repeated forced vital
capacity maneuvers (independent of exercise). It is postulated that in these two
subjects the bronchospasm seen following exercise protected by AWS was a result of
the multiple dynamic vital capacity measurements; such a phenomenon has been
described by Orehek et al. [12]. Table 5 compares the post-exercise pulmonary
function changes on the four separate test days for mean FEV, and MEF40%(P). As
can be seen, breathing AWS offered no advantage over the baseline study when
inhaled before or after exercise. Of interest is the significantly greater post-
metaproterenol response observed on the second study day during which AWS was
breathed during exercise.
Comparison of the initial day of the second study (no mask) to the mask day
demonstrated significant but incomplete protection. This effect was noted for all
functional parameters measured and is illustrated in Figs. 3 and 4 for FEV, and
MEF40%(P), respectively. Note that metaproterenol improved post-exercise func-
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Average (Mean i SD) Maximal Heart Rates (HR) and Ventilation (VE)
Achieved on Each Study Day of the Two Experiments
Heart Rate Minute Ventilation
(Beats/min) (L/min)
Study I (cascade humidifier)
Day 1 (ambient) 168.2 + 19.7 62.3 + 14.2
Day 2 (AWS during) 166.0 + 14.8 57.7 + 12.5
Day 3 (AWS after) 163.0 + 15.3 60.5 15.1
Day 4 (AWS before) 165.0 : 15.1 61.3 + 10.3
Study II (mask)
Day I (No mask) 163.8 + 12.4
Day 2 (mask) 166.6 : 12.3
Study I: Maximal work load 960 4 126 Kpm/min
Study II: Maximal work load 930 + 171 Kpm/min
tion to better than baseline on both test days, but that the response on the mask day
was greater.
Although for the group as a whole protection was only partial, in two of our
subjects the protection was complete, as illustrated by the series of flow volume
curves illustrated in Fig. 5.
In order to evaluate conditions within the mask we measured mask temperature by
means of a thermistor probe (Diatek, San Diego, CA) secured within the mask. We
also measured F co, inside the mask using a quadrupole mass spectrometer (Cen-
tronic, Croydon, England) to continuously monitor inspired CO2 concentration.
Measurements were made in six healthy subjects both at rest and at the end of six
minutes of submaximal exercise. Values for temperature and inspiratory F co, are
recorded in Table 6.
TABLE 3
Comparison of Baseline Pulmonary Function Obtained on the Initial Study Day
with Those Obtained on Subsequent Study Days
(Mean X SD)
Day 2 Day 3 Day 4
Study I (cascade (cascade (cascade
(cascade Day I humidifier humidifier humidifier
humidifier) (ambient) during) after) before)
FVC (L) 4.55 + 1.00 4.49 + 1.06 4.35 + 1.09 4.52 + 1.11
FEVy (L/Sec) 3.24 + 0.88 3.16 + 0.93 3.08 X 1.02 3.23 f 1.03
PEFR (L/Sec) 6.78 + 2.12 6.48 f 2.25 6.53 + 2.21 6.63 + 2.45
MEF40fo (L/Sec) 2.56 X 1.06 2.44 1.10 2.34 + 1.31 2.45 + 1.18
MEF40%(P) (L/Sec) 2.46 + 1.21 2.21 + 1.02 2.34 + 1.17 2.33 + 1.29
Study II Day I Day 2
(mask) (no mask) (with mask)
FVC 4.48 A 1.00 4.35 + 1.05
FEV, 3.06 + 0.99 2.93 + 1.03
PEFR 6.28 + 2.71 6.04 * 2.89
MEF40% 2.22 w 0.95 2.1 + 1.17
MEF40%o(P) 2.19 + 1.10 2.08 X 1.27
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TABLE 4
Exercise-Induced Bronchospasm (EIB) Demonstrated on the Initial Day of
Each Study, Expressed as a Percentage of Baseline
(Mean * SD)
Time Following Exercise
Baseline
(%70) 0 Min. 6 Min. 20 Min.*
Study I
(cascade humidifier)
FVC 100 94.2 :L 5.2** 92.1 f 7.8t 107.7 h 20.9
FEVy 100 93.1 * 15.5 85.6 + 12.4tt 112.4 i 16.9t
PEFR 100 95.2 + 14.4 83.7 15.33** 109.3 + 13.7t
MEF40o 100 94.4 + 29.1 72.2 + 25.7** 122.6 + 24.5t
MEF40% (P) 100 93.1 + 32.6 67.5 4 21.Stt 147.7 + 38.7tt
Study II
(mask)
FVC 100 93.1 * 6.7tt 91.1 k 9.1** 102.2 f 8.0
FEV, 100 90.0 + 12.4 80.6 i 13.6tt 106.8 + 11.1
PEFR 100 91.5 + 13.7 80.0 i 15.Stt 92.5 + 11.8
MEF40o 100 82.2 f 31.4 57.9 + 28.9tt 119.0 + 25.4t
MEF40% (P) 100 71.8 + 38.7 49.4 + 25.7tt 127.7 + 27.5**
*Ten minutes following inhalation of 2 metered doses of metaproterenol
tp < 0.05
**p < 0.01
DISCUSSION
We have demonstrated that breathing air warmed to body temperature and fully
saturated can considerably modify post-exercise bronchospasm in susceptible indi-
viduals. The protection afforded by breathing AWS during exercise supports the
hypothesis that respiratory heat exchange (RHE) acts as the major stimulus causing
EIB [5,13,14].
Measurements of EIB, under different environmental conditions, as a function of
the fall in FEV I (% aFEV ) has shown that in mild, relatively stable asthmatics
%AFEV, can be related by a linear regression to RHE [15]. Similarly manipulation
ofenvironmental condition and eucapneic hyperventilation have been shown to lead
to a degree of EIB predicted by the above regression [16]. Such findings strongly
suggest that RHE is the initiating mechanism for constriction following exercise.
Respiratory heat exchange has been characterized by the formula: RHE = VE
[HC(Ti-Te) + HV (WCi - WCe)] where RHE is measured in Kcal/min; VE is the
minute ventilation of the subject measured in e/min, BTPS; HC is the heat capacity
of air = 0.00034 Kcal/e.C°; Ti and Te the inspired and expired air temperature in °C;
HV the heat of vaporization of water = 0.58 Kcal/g; and WCi and Wce the inspired
and expired water content ofair in mgH2O/e air(M). Since HC and HVare constants
and Te and WCe are generally assumed to reflect BTPS conditions, three variables
influence the magnitude of RHE: namely VE, Ti, and WCi. Since VE is a function of
the level of exercise achieved, this variable cannot readily be influenced. The two
environmental conditions, on the other hand, Ti and WCi, can be readily manipu-
lated by simple means as we have shown in our study. Thefindingthat AWS inhaled
following exercise has no effect on EIB is not surprising. Many bronchodilating
agents, namely the beta agonists, methylxanthines, and carbon dioxide [17], have
been demonstrated to reverse EIB following its onset. These agents are felt to workSCHACHTER ET AL.
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125 I-
100 H 00
75 F
50 F p < 0.005
o No Mask
O With Mask 25 H
IEXERCISI
BASELINE 0 6
> TIME (min) FIG. 3. Post-exercise FEVy
20 changes for the group measured
10' POST on the two days of Study 11.
BRONCHODILATOR (Mean ± SE).
by direct bronchodilation and not to influence the mechanism underlying E1B. AWS
has no such bronchodilating properties. Ifone postulates that the bronchoconstrictor
mechanisms triggered by exercise are actively initiated only duringexercise, and that
AWS blocks this mechanism, its failure to alter post-exertional bronchospasm once
initiated is readily understood. The fact that EIB may only become apparent several
minutes following the cessation ofexercise has been attributed to thefact that there is
endogenous release of catecholamines during and immediately after exercise sup-
pressing bronchospasm. Hence, the onset of bronchoconstrictor forces probably
occurs during exercise. We had initially postulated that humidification ofinspired air
prior to exercise might alter EIB by somehow insulating the surface coat of the
airway but this did not, in fact, prove to be the case.
A practical implication of these findings is that the contribution of environmental
conditions must be assessed in evaluating any form of induced bronchospasm. In
1501
I
I
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O I l EXIER'!L;
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TIME (min) FIG. 4. Post exercise
20 MEF400o(P) changes for the
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SUBJECT NH
21 y.o.?
WITHOUT MASK
It
FLOW-
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LL/SC II, VOLU
I Liter VOLUME
6 MINUTES
AFTER
EXERCISE
IILI
FIG. 5. Sequential
changes in subject NH on
the two days of Study 11
demonstrating complete
protection against EIB.
particular, the temperature and humidity of ambient air may modify EIB responses
or for that matter any challenge in which there is interaction between RHE and other
airway irritants. Such considerations may be important in comparing the interactions
of inhalational challenges resulting in small differences; for example, those seen with
ambient levels of air pollutants, under different conditions of temperature and
humidity.
The second part of this study, which was suggested by the initial results, was
designed to investigate the usefulness ofwearing a simple mask as a potential means
for the prevention of EIB. All of the subjects tested noted that air in the mask was
warm and humid but not unpleasant. Wearing the mask during exercise was well
TABLE 6
Conditions Inside Test Mask Measured in Six Healthy Subjects at Rest and during Exercise
Inspiratory
Temperature (°C) Fco2(%)
Subject Rest Exercise Rest Exercise
ML 32.6 32.9 0.6 0.8
EM 32.2 32.2 0.2 0.2
EK 33.6 33.6 0.3 0.4
CS 33.3 33.3 0.3 0.6
BM 34.0 34.0 0.5 0.6
NS 32.7 31.8 0.3 0.5
X 33.1 33.0 0.37 0.52
SD 0.68 0.84 0.15 0.20
WITH MASK
10 MINUTES
FOLLOWING
METAPROTERONOL
IL
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tolerated, and the subjective impressions of our asthmatic group were that broncho-
spasm was considerably less following exercise when a mask was worn. These
impressions were confirmed by the objective findings of pulmonary function testing.
The data described showed a significant reduction in the degree of post-exercise
airway obstruction in all flow parameters when the mask was used during exercise,
and in some subjects this protection was complete (Fig. 5). The possibility that the
differences in RHE provided by the mask might be due to differences in VE on the
two study days seems unlikely in view of the relative constancy of this variable in
Study I (Table 2).
Although it was our hypothesis that the protective effect of wearing a mask was
due primarily to the increased temperature and humidity ofinspired air, the addition
of anatomic dead space within the mask raised the possibility that increased inspired
FCo, might account for the protective effect seen. Previous studies have shown that
the inhalation of high concentrations ofCO2 (6-8 percent) can, in fact, prevent EIB if
given during exercise [2]. Our measurements showed a residual FCo. of only 0.8
percent in the mask after exhalation. This concentration would not be sufficient to
cause bronchodilation of prophylactic value.
The fundamental mechanisms involved in EIB remain unknown. Two general
bronchoconstrictor mechanisms which have been suggested are autonomic nervous
system pathways [18,19,20] and the release ofmediators from airway-associated mast
cells [3,21,22]. However, studies refuting [15,23,24] these mechanisms as the sole of
mixed causes of EIB offer many contradictions which await further clarification.
Nevertheless, agents known to modify cholinergic [1,15,20] as well as mediator-
induced bronchospasm [1,25,26] have been used to successfully treat EIB. Such
agents unfortunately may be expensive or accompanied by undesirable side effects.
That therapeutic modalities unrelated to the alteration of the pharmacologic effects
of mediators or the cholinergic nervous system may be of value has been previously
suggested by the work of McNally et al., who have shown the therapeutic effect of
oropharyngeal anesthesia in EIB [18] and the work of Shturman-Ellstein et al. [27]
who have demonstrated the beneficial effect of nasal breathing in EIB. These results
imply that EIB may be modified at its earliest stages before nervous reflexes or
endogenous chemical agents are activated. Our study confirms the value ofthis type
of approach and suggests a practical method for treating EIB.
The practical implications of this study suggest that further protectionagainst EIB
might be achieved by using a mask that optimized the warmth and humidity of
inspired air. The mask used was not designed for this purpose and, in fact, contained
features that made it less than desirable. For example, the dead space was small and
prevented any significant reservoir of moist warm air. The use of such masks under
subfreezing conditions must also be studied as their usefulness may be limited by the
accumulation of ice on the surface of the mask. Further studies with masks
specifically designed for this problem appear warranted.
Our studies have confirmed the central role of heat exchange in EIB. Warming and
humidifying inspired air before and after exercise had no effect on the bronchospasm
following exercise; however, this environmental modification performed during
exercise completely abolished EIB. Based on these concepts we have demonstrated a
practical and simple means of altering respiratory heat exchange (RHE) and thereby
blunting EIB by the use of a simple mask. These observations suggest an adjunctive,
non-pharmacologic approach to the treatment of some forms of asthma, involving
respiratory heat loss.496 SCHACHTER ET AL.
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